Evidence map›Paper›PMID 39108856›Full record

ArticleHeliyon2024

Recurrent lacrimal gland adenoid cystic carcinoma: A case report and literature review.

Mingshen Ma, Tingting Ren, Rui Liu, Wei Wu, Xin Kang, Yan Hei, Yueyue Li, Jing Li, Xinji Yang, Yong Tao

Abstract readCase Reports
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mingshen MaDepartment of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, 100027, Beijing, China.
Tingting RenDepartment of Ocular Oncology, Beijing Tongren Hospital, Capital Medical University, 100005, Beijing, China.
Rui LiuDepartment of Ocular Oncology, Beijing Tongren Hospital, Capital Medical University, 100005, Beijing, China.
Wei WuSenior Department of Ophthalmology, 3rd Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
Xin KangSenior Department of Ophthalmology, 3rd Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
Yan HeiSenior Department of Ophthalmology, 3rd Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
Yueyue LiSenior Department of Ophthalmology, 3rd Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
Jing LiDepartment of Ocular Oncology, Beijing Tongren Hospital, Capital Medical University, 100005, Beijing, China.
Xinji YangSenior Department of Ophthalmology, 3rd Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.
Yong TaoDepartment of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, 100027, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Lacrimal gland adenoid cystic carcinoma (LGACC) is characterized by a high rate of recurrence, perineural invasion, and propensity for distant metastasis, resulting in poor prognosis. This case report aimed to highlight the diagnostic and therapeutic challenges of LGACC, underscore the importance of resectioning the tumor as completely as possible for the first time, adhere to postoperative adjuvant therapy, and provide detailed insights into its surgical and diagnostic management that may not be extensively covered in large case series and meta-analyses. Case presentation: A 34-year-old man presented with progressive left eye proptosis for 4 months. Initial evaluation and imaging led to a high suspicion of LGACC, which was confirmed after an eye-sparing excision of the left orbital tumor. The patient declined to undergo postoperative radiotherapy, which was recommended after the surgery. Thus, despite surgical intervention, the patient experienced tumor recurrence 3 months post-surgery, leading to orbital exenteration. Pathological examination confirmed the presence of poorly differentiated LGACC.This time the patient underwent postoperative radiotherapy, as recommended. However, despite local control, the patient developed an intracranial metastasis within a year. Conclusion: LGACC presents significant diagnostic and therapeutic challenges owing to its insidious onset, lack of specific symptoms, and high potential for recurrence and metastasis. Thus, this case emphasizes the need for early diagnosis, aggressive treatment, and adherence to postoperative adjuvant therapy to improve patient outcomes. Future research should focus on understanding the pathogenesis of LGACC and on developing standardized diagnostic and treatment protocols to enhance patient prognosis and survival.

Indexed as

Case reportEye-sparing excisionLacrimal gland adenoid cystic carcinomaPostoperative radiotherapyRecurrent

Identifiers

PMID39108856
PMCPMC11301145

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.